HR 6214119th CongressIn Committee
Kidney Care Access Protection Act
Standard Summary
Balanced plain-English summary
This bill would amend Medicare payment rules to improve access to innovative treatments for end-stage renal disease. It extends transitional add-on payments for new kidney dialysis drugs, biologicals, and devices; creates a permanent post-transitional drug adjustment; addresses Medicare Advantage payment for innovative kidney therapies; adjusts dialysis payment updates for forecast error; and expands Medicare coverage for kidney disease screening and education.
Key Points
- 1Extends and modifies Medicare add-on payments for new renal dialysis drugs, biologicals, and devices.
- 2Creates a permanent post-TDAPA payment adjustment for certain kidney care drugs and biologicals.
- 3Requires Medicare Advantage direct payment adjustments for innovative kidney therapies.
- 4Expands Medicare annual wellness benefits to include chronic kidney disease screening.
- 5Broadens access to Medicare kidney disease education, including through renal dialysis facilities.
Impact Areas
End-stage renal disease patientsDialysis facilitiesMedicare Advantage enrolleesKidney care drug and device manufacturersMedicare providers and suppliers
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026